| Page No 1 2 3 4 |
| Phrase | Consultant | Town | Special Interests |
| Acute haematological oncology | *Consultant(s)* | *Towns* | Acute haematological oncology |
| acute oncology | *Consultant(s)* | *Towns* | Acute medicine, general endocrine problems, acute oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, urological oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, gynaecological cancer, breast cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, central nervous system cancers, breast cancer, lung cancer, Cyberknife-SBRT expertise |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, sarcoma |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, neuro-oncology, haematological malignancy radiotherapy, cancer of unknown primary |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, gastrointestinal oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, medical oncology, gynaecological oncology, tumour specific antigens, biomarkers of tumour proliferation and apoptosis, breast cancer, immunotherapy and cancer vaccines |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, lung cancer, breast cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, head and neck oncology, radiotherapy late effects |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, colorectal cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, gastrointestinal cancers |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, central nervous system malignancies, upper gastrointestinal malignancies, neuroendocrine tumour, colorectal malignancies, hepatobiliary malignancies, Urological malignancies |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, lung cancer, mesothelioma, non-melanoma skin cancers |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, colorectal cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, upper gastrointestinal cancer, neuro-oncology, urological oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, head and neck cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, sarcoma, teenage and young adult cancer, germ cell tumours, lung cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, lung cancer, mesothelioma, thoracic oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, lung cancer, brain tumours |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, head and neck cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, neuro-oncology, thyroid cancer, head and neck oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, lung cancer, sarcoma |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, hepatobiliary cancer, upper gastrointestinal cancer, lymphoma |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, prostate cancer, breast cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, colorectal cancer, lung cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, gastrointestinal cancers |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, upper and lower gastrointestinal oncology, lung cancer, chemotherapy, radiotherapy |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, head and neck cancer, melanoma |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, gynaecological cancers |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, urological oncology, anal cancer, colorectal cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, intensity modulated radiotherapy - IMRT, chemotherapy, colorectal cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, gynaecological oncology, urological oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, malignant melanoma, renal cancer, biological therapies, novel therapies |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, gynaecological oncology, sarcoma, breast cancer, lymphoma, general oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, haemato-oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, radiotherapy for osteoarthritis, radiotherapy for tendinopathy, radiotherapy for non-melanoma skin cancer, radiotherapy for Dupuytren's contracture and Ledderhose disease, radiotherapy for plantar fasciitis and achilles tendinopathy, radiotherapy for keloid scarring, radiotherapy for bursitis |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast cancer, urological cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, colorectal cancer, upper gastrointestinal cancers |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, urological oncology, testicular cancer, penis and breast cancer, prostate cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, head and neck cancer, lung cancer, stereotactic ablative body radiotherapy - SABR |
| Page No 1 2 3 4 |
